BRPI0511371A - esterol enriquecido e misturado com anfotericina lamelada, intercalada com liposomos em solução salina e o processo para a sua preparação - Google Patents
esterol enriquecido e misturado com anfotericina lamelada, intercalada com liposomos em solução salina e o processo para a sua preparaçãoInfo
- Publication number
- BRPI0511371A BRPI0511371A BRPI0511371-7A BRPI0511371A BRPI0511371A BR PI0511371 A BRPI0511371 A BR PI0511371A BR PI0511371 A BRPI0511371 A BR PI0511371A BR PI0511371 A BRPI0511371 A BR PI0511371A
- Authority
- BR
- Brazil
- Prior art keywords
- liposomes
- amphotericin
- saline
- mixed
- lamellated
- Prior art date
Links
- 239000002502 liposome Substances 0.000 title abstract 3
- 229930183010 Amphotericin Natural products 0.000 title abstract 2
- QGGFZZLFKABGNL-UHFFFAOYSA-N Amphotericin A Natural products OC1C(N)C(O)C(C)OC1OC1C=CC=CC=CC=CCCC=CC=CC(C)C(O)C(C)C(C)OC(=O)CC(O)CC(O)CCC(O)C(O)CC(O)CC(O)(CC(O)C2C(O)=O)OC2C1 QGGFZZLFKABGNL-UHFFFAOYSA-N 0.000 title abstract 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 title abstract 2
- 229930182558 Sterol Natural products 0.000 title abstract 2
- 229940009444 amphotericin Drugs 0.000 title abstract 2
- APKFDSVGJQXUKY-INPOYWNPSA-N amphotericin B Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-INPOYWNPSA-N 0.000 title abstract 2
- 239000011780 sodium chloride Substances 0.000 title abstract 2
- 150000003432 sterols Chemical class 0.000 title abstract 2
- 235000003702 sterols Nutrition 0.000 title abstract 2
- 239000003814 drug Substances 0.000 abstract 2
- 208000030852 Parasitic disease Diseases 0.000 abstract 1
- 239000008280 blood Substances 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 238000009830 intercalation Methods 0.000 abstract 1
- 230000003834 intracellular effect Effects 0.000 abstract 1
- 244000000040 protozoan parasite Species 0.000 abstract 1
- 238000000527 sonication Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Manufacturing Of Micro-Capsules (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN1113DE2004 | 2004-06-11 | ||
| PCT/IN2005/000193 WO2005120460A1 (en) | 2004-06-11 | 2005-06-13 | Sterol enriched mixed lammelarity amphotericin intercalating liposomes in saline and the process for their preparation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0511371A true BRPI0511371A (pt) | 2008-03-11 |
Family
ID=34972096
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0511371-7A BRPI0511371A (pt) | 2004-06-11 | 2005-06-13 | esterol enriquecido e misturado com anfotericina lamelada, intercalada com liposomos em solução salina e o processo para a sua preparação |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20070218119A1 (enExample) |
| EP (1) | EP1771156B8 (enExample) |
| JP (1) | JP4966855B2 (enExample) |
| CN (1) | CN101014322A (enExample) |
| AT (1) | ATE476965T1 (enExample) |
| AU (1) | AU2005251572B2 (enExample) |
| BR (1) | BRPI0511371A (enExample) |
| DE (1) | DE602005022876D1 (enExample) |
| WO (1) | WO2005120460A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI1003990B1 (pt) * | 2009-10-16 | 2021-09-14 | Lifecare Innovations Pvt. Ltd | Formulação para o tratamento de infecções fúngicas |
| CN108602025B (zh) | 2016-03-04 | 2021-02-26 | 栗田工业株式会社 | 选择性透过膜及其制造方法、使用该选择性透过膜的水处理方法 |
| PT3694526T (pt) | 2017-10-11 | 2025-01-20 | Univ Illinois | Resgate independente do genótipo da fibrose quística com canais de bicarbonato de moléculas pequenas |
| IL315719A (en) | 2022-03-21 | 2024-11-01 | Univ Illinois | Prosthetic assemblies of ion channels containing lipid-coated amphotericin B crystals |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2134869A (en) * | 1983-02-15 | 1984-08-22 | Squibb & Sons Inc | Method of preparing liposomes and products produced thereby |
| US4744989A (en) * | 1984-02-08 | 1988-05-17 | E. R. Squibb & Sons, Inc. | Method of preparing liposomes and products produced thereby |
| US4766046A (en) * | 1985-09-27 | 1988-08-23 | Liposome Technology, Inc. | Stabilized liposome/amphotericin composition and method |
-
2005
- 2005-06-13 CN CNA200580023366XA patent/CN101014322A/zh active Pending
- 2005-06-13 EP EP05759293A patent/EP1771156B8/en not_active Expired - Lifetime
- 2005-06-13 AT AT05759293T patent/ATE476965T1/de not_active IP Right Cessation
- 2005-06-13 JP JP2007526704A patent/JP4966855B2/ja not_active Expired - Fee Related
- 2005-06-13 BR BRPI0511371-7A patent/BRPI0511371A/pt active Search and Examination
- 2005-06-13 US US11/570,379 patent/US20070218119A1/en not_active Abandoned
- 2005-06-13 WO PCT/IN2005/000193 patent/WO2005120460A1/en not_active Ceased
- 2005-06-13 AU AU2005251572A patent/AU2005251572B2/en not_active Ceased
- 2005-06-13 DE DE602005022876T patent/DE602005022876D1/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| EP1771156A1 (en) | 2007-04-11 |
| WO2005120460A1 (en) | 2005-12-22 |
| AU2005251572B2 (en) | 2010-03-11 |
| AU2005251572A1 (en) | 2005-12-22 |
| US20070218119A1 (en) | 2007-09-20 |
| JP2008501782A (ja) | 2008-01-24 |
| EP1771156B1 (en) | 2010-08-11 |
| CN101014322A (zh) | 2007-08-08 |
| JP4966855B2 (ja) | 2012-07-04 |
| ATE476965T1 (de) | 2010-08-15 |
| DE602005022876D1 (de) | 2010-09-23 |
| EP1771156B8 (en) | 2010-09-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0415858A (pt) | compostos de medicamentos terapêuticos modificados por tocoferol | |
| BRPI0513200A (pt) | uso de um anticorpo anti-igf-1r na preparação de um medicamento para tratamento combinado para malignidades não-hematológicas | |
| CY1111359T1 (el) | Μεμαντινη για την θεραπεια ηπιας εως μετριας ασθενειας alzheimer | |
| CA2690111A1 (en) | Anthelmintic combination | |
| AR047779A1 (es) | Composiciones y metodos para tratar diabetes | |
| BR0008135A (pt) | Composto, métodos para tratar uma infecção por vìrus em um ser humano e para tratar uma infecção pelo vìrus da hepatite b em um ser humano, composição farmacêutica, uso de um composto, método para liberar um composto, pacote para paciente, processo para a preparação de um composto | |
| PT1299130E (pt) | Processo papa o tratamento e prevencao de doencas infecciosas | |
| BRPI0418157A (pt) | terapêutica de tumores alogênicos | |
| BRPI0513622A (pt) | aplicação de combinações auto-emulsificantes (seeds) de excipientes lipìdicos, de surfactantes; composição farmacêutica contendo um princìpio ativo e uma combinação auto-emulsificante (seeds) de excipientes lipìdicos, de surfactantes; e processo para a preparação de combinações auto-emulsificantes (seeds) de excipientes lipìdios, de surfactantes | |
| EA201001287A1 (ru) | Лечение гиперглицемии 25-гидроксивитамином d3 | |
| EP1771156B8 (en) | Sterol enriched mixed lamellarity amphotericin intercalating liposomes in saline and the process for their preparation | |
| BR0116653A (pt) | Medicamento contendo uma poliamina como substância ativa | |
| BRPI0414518A (pt) | composições farmacêuticas e métodos compreendendo combinações de derivados de 2-alquilideno-19-nor-vitamina d e hormÈnio paratireoidiano | |
| AR048318A1 (es) | Formulaciones de matriz orales que comprenden licarbazepina | |
| DE50113974D1 (de) | Kombinationspräparate von 3-n-formylhydroxylaminopropylphosphonsäurederivaten oder 3-n-acetylhydroxylaminopropylphosphonsäurederivaten mit speziellen pharmazeutischen wirkstoffen | |
| BR0108283A (pt) | Uso de fosfato de estramustina ou um seu metabólito na preparação de um medicamento, agente para uso na potenciação da eficácia terapêutica de um taxano, combinação que potencia a eficácia terapêutica de um taxano, processo e método de potenciar a eficácia terapêutica de um taxano | |
| EA200501252A1 (ru) | Липосомальная композиция, способ ее получения и лекарственное средство на ее основе (варианты) | |
| BRPI0412506A (pt) | células autólogas que induzem à autotoleráncia de origem monocìtica e seu uso em preparações farmacêuticos | |
| Ahmed et al. | Effect of wet cupping therapy on virulent cellulitis secondary to honey bee sting-a case report | |
| MXPA05005021A (es) | Pure de papaya y uso del mismo. | |
| Turlaev et al. | Socio-economic aspects of the development of hirudotherapy in Russia | |
| Kupferschmidt | 'A sigh of relief': New malaria drug succeeds in clinical trial as existing treatments falter. | |
| WO2006089120A3 (en) | Compositions, methods of use and preparation of 2,6-diisopropyl phenol and analogs for ischemic injury | |
| BRPI0602179A (pt) | composição farmacêutica compreendendo ciclobenzaprina e aceclofenaco em combinação | |
| BRPI0417797A (pt) | soro sangüìneo biologicamente ativo, métodos para produzi-lo e seus usos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B06T | Formal requirements before examination [chapter 6.20 patent gazette] | ||
| B11E | Dismissal acc. art. 34 of ipl - requirements for examination incomplete | ||
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS. |
|
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B11T | Dismissal of application maintained [chapter 11.20 patent gazette] |